Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial
- PMID: 15302194
- DOI: 10.1016/S0140-6736(04)16809-8
Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial
Abstract
Background: Although delivery is widely used for preterm babies failing to thrive in utero, the effect of altering delivery timing has never been assessed in a randomised controlled trial. We aimed to compare the effect of delivering early with delaying birth for as long as possible.
Methods: 548 pregnant women were recruited by 69 hospitals in 13 European countries. Participants had fetal compromise between 24 and 36 weeks, an umbilical-artery doppler waveform recorded, and clinical uncertainty about whether immediate delivery was indicated. Before birth, 588 babies were randomly assigned to immediate delivery (n=296) or delayed delivery until the obstetrician was no longer uncertain (n=292). The main outcome was death or disability at or beyond 2 years of age. Disability was defined as a Griffiths developmental quotient of 70 or less or the presence of motor or perceptual severe disability. Analysis was by intention-to-treat. This trial has been assigned the International Standard Randomised Controlled Trial Number ISRCTN41358726.
Findings: Primary outcomes were available on 290 (98%) immediate and 283 (97%) deferred deliveries. Overall rate of death or severe disability at 2 years was 55 (19%) of 290 immediate births, and 44 (16%) of 283 delayed births. With adjustment for gestational age and umbilical-artery doppler category, the odds ratio (95% CrI) was 1.1 (0.7-1.8). Most of the observed difference was in disability in babies younger than 31 weeks of gestation at randomisation: 14 (13%) immediate versus five (5%) delayed deliveries. No important differences in the median Griffiths developmental quotient in survivors was seen.
Interpretation: The lack of difference in mortality suggests that obstetricians are delivering sick preterm babies at about the correct moment to minimise mortality. However, they could be delivering too early to minimise brain damage. These results do not lend support to the idea that obstetricians can deliver before terminal hypoxaemia to improve brain development.
Comment in
-
When to deliver the stunted fetus?Lancet. 2004 Aug 7-13;364(9433):483-4. doi: 10.1016/S0140-6736(04)16823-2. Lancet. 2004. PMID: 15302175 No abstract available.
-
GRIT: concern about external validity.Lancet. 2005 Jan 29-Feb 4;365(9457):384; author reply 385. doi: 10.1016/S0140-6736(05)17821-0. Lancet. 2005. PMID: 15680449 No abstract available.
Similar articles
-
A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation.BJOG. 2003 Jan;110(1):27-32. doi: 10.1046/j.1471-0528.2003.02014.x. BJOG. 2003. PMID: 12504932 Clinical Trial.
-
Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes.Cochrane Database Syst Rev. 2019 Sep 17;9(9):CD003248. doi: 10.1002/14651858.CD003248.pub4. Cochrane Database Syst Rev. 2019. PMID: 31529790 Free PMC article.
-
2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial.Lancet. 2015 May 30;385(9983):2162-72. doi: 10.1016/S0140-6736(14)62049-3. Epub 2015 Mar 5. Lancet. 2015. PMID: 25747582 Clinical Trial.
-
Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT.Health Technol Assess. 2023 Dec;27(28):1-22. doi: 10.3310/CWWH0622. Health Technol Assess. 2023. PMID: 36547875 Free PMC article. Clinical Trial.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Fetal Growth Restriction - Diagnostic Work-up, Management and Delivery.Geburtshilfe Frauenheilkd. 2020 Oct;80(10):1016-1025. doi: 10.1055/a-1232-1418. Epub 2020 Sep 25. Geburtshilfe Frauenheilkd. 2020. PMID: 33012833 Free PMC article.
-
Administration of Antenatal Corticosteroids: Optimal Timing.Geburtshilfe Frauenheilkd. 2024 Jan 3;84(1):48-58. doi: 10.1055/a-2202-5363. eCollection 2024 Jan. Geburtshilfe Frauenheilkd. 2024. PMID: 38205043 Free PMC article.
-
Dysregulation of integrin αvβ3 and α5β1 impedes migration of placental endothelial cells in fetal growth restriction.Development. 2022 Oct 1;149(19):dev200717. doi: 10.1242/dev.200717. Epub 2022 Oct 4. Development. 2022. PMID: 36193846 Free PMC article.
-
Neurodevelopment Outcome in Children with Fetal Growth Restriction at Six Years of Age: A Retrospective Cohort Study.Int J Environ Res Public Health. 2022 Sep 3;19(17):11043. doi: 10.3390/ijerph191711043. Int J Environ Res Public Health. 2022. PMID: 36078758 Free PMC article.
-
Understanding placental nutrient transfer--why bother? New biomarkers of fetal growth.J Physiol. 2009 Jul 15;587(Pt 14):3431-40. doi: 10.1113/jphysiol.2009.172403. Epub 2009 May 5. J Physiol. 2009. PMID: 19417095 Free PMC article. Review.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous